Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2003
Business Overview: The Company operates outpatient physical and occupational therapy clinics providing pre- and post-operative care. As of September 30, 2003, it operated 235 clinics in 35 states. The Company significantly reduced the development of new clinic partnerships in 2003, shifting toward wholly-owned clinics.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2003 | Nine Months Ended Sep 30, 2003 |
|---|---|---|
| Net Revenues | $26,854 | $78,863 |
| Operating Income | $4,472 | $13,565 |
| Net Income | $1,901 | $5,901 |
| Diluted EPS | $0.15 | $0.48 |
| Cash and Cash Equivalents | $14,683 | $14,683 (Ending Balance) |
| Net Cash from Operating Activities | N/A | $13,451 |
| Total Debt (Convertible Notes) | $2,333 (Current) | $2,333 (Current) |
| Current Ratio | 6.04:1 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 13% for both the three-month and nine-month periods compared to the prior year, driven by a 12% increase in patient visits (282,000 visits in Q3; 832,000 in YTD) and a slight increase in revenue per visit.
- Profitability Decline: Despite revenue growth, Net Income declined 6% in Q3 ($1.9M vs. $2.0M) and 8% in the nine-month period ($5.9M vs. $6.4M). This was primarily due to increased operating costs.
- Cost Increases:
- Salaries: Increased 19% in Q3 and 17% YTD, driven by new clinic staffing and higher bonuses for clinic directors.
- Corporate Costs: Increased 28% in Q3 and 24% YTD due to higher salaries, recruitment fees, severance, and insurance premiums.
- Bad Debt Improvement: The provision for doubtful accounts decreased significantly (112% in Q3, 46% YTD) due to enhanced collection efforts, resulting in a benefit of $45,000 in Q3.
- Liquidity: Cash and cash equivalents increased by $7.1 million to $14.7 million, funded primarily by operating cash flows of $13.5 million.
Outlook, Risks, and Management Commentary
- Clinic Development: The Company opened 40 clinics in the first nine months of 2003. The goal for 2003 is to open at least 47 clinics total. New clinics are expected to incur initial operating losses.
- Medicare Reimbursement Limit: A $1,590 annual cap on Medicare therapy services per patient was implemented effective September 1, 2003. Management does not expect a material adverse impact on 2003 income but warns of a potential 10% revenue reduction in 2004 if the limit remains in place for the full year and is not mitigated by secondary insurance or marketing efforts.
- Debt Maturity: The Company has $2.3 million in Convertible Subordinated Notes due June 30, 2004. If the stock price is below the conversion price of $3.33 at maturity, the Company will need to use cash to repay the note. Current cash reserves ($14.7M) are sufficient to cover this obligation.
- Share Repurchase: A new program authorized in February 2003 allows for the repurchase of up to 250,000 shares. No shares have been repurchased under this new program as of September 30, 2003.
Investor Verification Checklist
- Medicare Cap Impact: Verify the actual impact of the $1,590 Medicare reimbursement limit on Q4 2003 and 2004 revenue projections.
- Debt Conversion: Monitor the stock price relative to the $3.33 conversion price of the Series C Note maturing in June 2004 to assess cash outflow requirements.
- New Clinic Performance: Track the ramp-up time and profitability of the 40 new clinics opened in 2003 to ensure they meet historical performance expectations.
- Corporate Cost Control: Review the sustainability of the 24-28% increase in corporate office costs and its effect on future operating margins.
- Bad Debt Reserves: Confirm that the reduced provision for doubtful accounts reflects a permanent improvement in collection rates rather than a temporary anomaly.